Table 1.
Patient number | Age (yrs)/gendera | Siteb | Diagnosis | Grade/stage | Procedure | Duration of follow-up (months) | Range of motion: involved/uninvolved (%) | Grip strength: involved/uninvolved (%) | Functional analysisd | Remarks |
---|---|---|---|---|---|---|---|---|---|---|
1 | 21/F | R | Giant cell tumour | 3 | Osteoarticular allograft | 42.3 | 67% | 64% | Excellent | Revised plate and bone grafting |
2 | 56/F | R | Giant cell tumour | 3 | Osteoarticular allograft | 90.9 | 73% | 70% | Good | - |
3 | 61/F | R | Giant cell tumour | 3 | Osteoarticular allograft | 50.4 | NAc | NA | Good | - |
4 | 41/M | R | Giant cell tumour, recurrent | 3 | Osteoarticular allograft | 54.0 | Fusion | Fusion | Good | Ulnar translocation radiocarpal |
5 | 43/M | R | Giant cell tumour | 3 | Osteoarticular allograft | 41.5 | 72% | 77% | Excellent | - |
6 | 36/M | L | Giant cell tumour | 3 | Osteoarticular allograft | 42.0 | 65% | 58% | Excellent | Revised plate and bone grafting |
7 | 39/F | R | Giant cell tumour | 3 | Osteoarticular allograft | 48.2 | 78% | 80% | Excellent | - |
8 | 25/M | R | Giant cell tumour, recurrent | 3 | Osteoarticular allograft | 52.2 | 80% | 84% | Excellent | - |
9 | 21/F | R | Giant cell tumour | 3 | Fibular autograft | 94.4 | 64% | 48% | Excellent | - |
10 | 34/M | R | Giant cell tumour | 3 | Fibular autograft | 95.5 | NA | NA | Good | - |
11 | 27/M | L | Giant cell tumour | 3 | Fibular autograft | 57.2 | 78% | 76% | Excellent | - |
12 | 18/F | R | Giant cell tumour | 3 | Fibular autograft | 71.8 | 73% | 58% | Excellent | - |
13 | 24/M | R | Malignant fibrous histiocyxoma | IIB | Fibular autograft | 57.9 | 77% | 82% | Excellent | - |
14 | 27/F | L | Simple bone cyst | 3 | Fibular autograft | 50.6 | 70% | 64% | Excellent | - |
15 | 43/M | R | Well-differentiated osteosarcoma | IB | Fibular autograft | 58.8 | 80% | 86% | Excellent | - |
aF female; M male
bR right; L left
cNA data not applicable
dMusculoskeletal Tumour Society functional classification